D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms [Medical_Sciences]

The oncoproteins MDM2 and MDMX negatively regulate the activity and stability of the tumor suppressor protein p53, conferring tumor development...